➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Merck
Baxter
Moodys
Dow

Last Updated: June 16, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Quinagolide


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Quinagolide?

Quinagolide is an investigational drug.

There have been 4 clinical trials for Quinagolide. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2018.

The most common disease conditions in clinical trials are Endometriosis, Syndrome, and Ovarian Hyperstimulation Syndrome. The leading clinical trial sponsors are Ferring Pharmaceuticals, Instituto Valenciano de Infertilidad, IVI VALENCIA, and [disabled in preview].

There are two hundred and twenty-nine US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Quinagolide
TitleSponsorPhase
Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/AdenomyosisFerring PharmaceuticalsPhase 2
Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related PainFerring PharmaceuticalsPhase 2
Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation SyndromeInstituto Valenciano de Infertilidad, IVI VALENCIAPhase 2

See all Quinagolide clinical trials

Clinical Trial Summary for Quinagolide

Top disease conditions for Quinagolide
Top clinical trial sponsors for Quinagolide

See all Quinagolide clinical trials

US Patents for Quinagolide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Quinagolide   Get Started Free .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA)   Get Started Free
Quinagolide   Get Started Free Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP) BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Get Started Free
Quinagolide   Get Started Free Fast dissolving pharmaceutical composition Ferring B.V. (Hoofddorp, NL)   Get Started Free
Quinagolide   Get Started Free Aryl-cyanoguanidine compounds Bayer Pharma Aktiengesellschaft (Berlin, DE)   Get Started Free
Quinagolide   Get Started Free Glucocerebrosidase modulators and uses thereof Alectos Therapeutics Inc. (Burnaby, CA)   Get Started Free
Quinagolide   Get Started Free Fast dissolving pharmaceutical composition Ferring B.V. (Hoofddorp, NL)   Get Started Free
Quinagolide   Get Started Free Combination of PI3K-inhibitors BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Quinagolide

Drugname Country Document Number Estimated Expiration Related US Patent
Quinagolide Argentina AR105592 2035-08-03   Get Started Free
Quinagolide Australia AU2016302243 2035-08-03   Get Started Free
Quinagolide Canada CA2994404 2035-08-03   Get Started Free
Quinagolide China CN108026026 2035-08-03   Get Started Free
Quinagolide European Patent Office EP3331851 2035-08-03   Get Started Free
Quinagolide Hong Kong HK1247608 2035-08-03   Get Started Free
Quinagolide Japan JP2018528179 2035-08-03   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKesson
Express Scripts
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.